Skip to main navigation

Main Nav

About Us
Scientific Platform
Our Pipeline
Career Opportunities
Investors & Media

Press Releases

IR Nav

Overview
Press Releases
Events
Presentations
Annual Reports
Corporate Governance
SEC Filings
Stock Information
Analyst Coverage
FAQs
Email Alerts
Investor Contact

Shareholder Tools

Press Releases

Year

Gritstone Oncology to Webcast a Review of the Clinical Immunogenicity Data from its Neoantigen-based Immunotherapies that will be Presented at the ESMO Immuno-Oncology Congress

December 9, 2019

Gritstone Oncology to Present at the Piper Jaffray Annual Healthcare Conference

November 26, 2019

Gritstone Oncology Reports Third Quarter 2019 Financial Results and Recent Highlights

November 12, 2019

Gritstone Oncology Announces Data on Novel Shared Tumor-Specific Neoantigens Identified by its EDGE Platform and Contained Within its SLATE Immunotherapy

November 5, 2019

Gritstone Oncology to Webcast Investor Event Reviewing its Neoantigen-based Immunotherapies During SITC Conference

October 31, 2019

Gritstone Oncology Announces Upcoming Presentation on Novel Shared Neoantigens Included within “Off-The-Shelf” SLATE Immunotherapy at SITC 2019 Annual Meeting

October 7, 2019

Gritstone Oncology to Present at Cantor Global Healthcare Conference

September 26, 2019

Gritstone Oncology Announces Changes to its Board of Directors, Including the Appointment of Biotech Veteran Dr. Elaine V. Jones

September 12, 2019

Gritstone Oncology Announces First Patient Dosed with SLATE, its “Off-The-Shelf” Neoantigen Immunotherapy

August 14, 2019

Gritstone Oncology Reports Second Quarter 2019 Financial Results and Recent Highlights

August 12, 2019

Pagination

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
Next page
Last page

© 2021 Gritstone Bio |

Footer Links

Privacy Policy
Terms of Use
Contact

socials

Top